USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Lifescan Scotland Limited

USPTO PatentsView assignee record — 49 granted patents across 20 technology areas, active 2015–2018. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).

49
Total patents granted
20
CPC technology areas
15.5
Avg claims per patent
-100%
5-year filing velocity

The verdict

Lifescan holds 49 US patents across 20 technology areas — rank #6,808 of 50,000 tracked assignees.

#6,808
of 50,000 US assignees by volume
Top 40%
by Innovation Score (38.6/100)
15.5
avg claims per patent
-100%
filing velocity, last 5 yrs

Portfolio overview

LifeScan Scotland Limited has been granted 49 US utility patents between 2015 and 2018, placing LifeScan Scotland Limited at rank #6,808 across all assignees tracked by PlainPatent. This portfolio spans 20 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.5 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a Foreign Corporation, LifeScan Scotland Limited is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 38.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 49 in the 2015–2019 window — a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. LifeScan Scotland Limited's 15.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 20 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark LifeScan Scotland Limited against peers pursuing similar technology classes.

How does LifeScan compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows LifeScan holds 49 patents — placing it at rank #6,808 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

LifeScan's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

39 Top 40% higher than 60% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). This entry sits in this band. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2018

0510152025 2015201620172018 3
USPTO utility patent grants by year · 2015–2018

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
LifeScan Scotland Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 13 26.5%
2016 22 44.9%
2017 11 22.4%
2018 3 6.1%

Which technologies does LifeScan Scotland Limited patent most?

Top 15 of 20 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Declining

Where it ranks

Overall rank by patents

#6,808

Across all tracked assignees

Innovation Score

38.6 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does LifeScan Scotland Limited hold?
LifeScan Scotland Limited holds 49 US granted patents filed between 2015 and 2018, spanning 20 technology areas.
What is LifeScan Scotland Limited's Innovation Score?
LifeScan Scotland Limited has an Innovation Score of 38.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does LifeScan Scotland Limited focus on?
LifeScan Scotland Limited's top technology area is G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES) with 42 patents. The company has filed patents in 20 CPC subclasses total.
Is LifeScan Scotland Limited's patent filing rate increasing or decreasing?
LifeScan Scotland Limited's recent filing velocity is -100% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for LifeScan Scotland Limited's patents?
LifeScan Scotland Limited's patents average 15.5 claims each. This falls within the standard range, providing solid legal coverage.
How is the LifeScan Scotland Limited patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How to use this portfolio

Lifescan's 49 grants land it in the top 40% by Innovation Score — but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance — Lifescan ranks #6,808 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in G01N — see who else leads that technology area. G01N leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity — not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Data sources used on this page
  • USPTO PatentsView — the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) — the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search — the official interface to verify the status of any individual patent. ppubs.uspto.gov